Log In
Print
BCIQ
Print
Print this Print this
 

dibotermin alfa (PF-5208771)

Also known as: InductOs (rhBMP-2/ACS)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionRecombinant human bone morphogenic protein 2 (BMP2) with Absorbable Collagen Sponge (ACS) matrix
Molecular Target Bone morphogenetic protein receptor type I (BMPRI) ; Bone morphogenetic protein receptor type II (BMPRII)
Mechanism of ActionBone morphogenic protein (BMP) type I receptor agonist; Bone morphogenic protein (BMP) type II receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationBone repair
Indication DetailsTreat acute tibia fractures in adults; Treat fracture repair
Regulatory Designation
Partner Astellas Pharma Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today